(E)-Ethyl 3-(pyrrolidin-1-yl)but-2-enoate, 95.0%, 1g

2-METHYL-2-VINYLOXIRANE, 97.0%, 25g

N1,N1-Dibutyl-N4,N4-bis(4-(dibutylamino)phenyl)benzene-1,4-diamine, 95%, 5g

(R)-3-((tert-Butoxycarbonyl)amino)-2-methylpropanoic acid, 95.0%, 5g

Isoxazol-5-yl-methylamine, 95.0%, 250mg

1,2,4,5-Tetraethynylbenzene, 97%, 2.5g

quinazoline-4-thiol, 1g

1-Phenyl-1-nonadecanone, 97%, 5g

Boc-D-Pro-OSu, 96%, 5g

Methyl 4-(5-nitropyridin-2-yl)butanoate, 98%, 5g

N-Butylethylenediamine>95.0%(GC)25mL

(4S,4'S)-2,2'-(2-(4-(tert-Butyl)phenyl)ethane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 97%, 1g

2-(3-Methyl-2-pyridinyl)-1,3-propanediol, 250mg